ACOX1 and melanoma: (36) reported a specific vulnerability of BRAFi/MEKi-persistent melanoma cells resulting from their predominant dependency on ACOX1-mediated peroxisomal fatty acid β-oxidation that can potentially translate into therapeutic opportunities.